Sign in or Register   Sign in or Register
  |  

Mouse Anti-GCK Recombinant Antibody (CBFYH-0289) (CBMAB-H1161-FY)

This product is mouse antibody that recognizes GCK. The antibody CBFYH-0289 can be used for immunoassay techniques such as: FC, IF, IHC, WB.
See all GCK antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBFYH-0289
Antibody Isotype
IgG1
Application
FC, IF, IHC, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, PH 7.3, 1% BSA, 50% glycerol
Preservative
0.02% Sodium azide
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Glucokinase
Introduction
This gene encodes a member of the hexokinase family of proteins. Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. The use of multiple promoters and alternative splicing of this gene result in distinct protein isoforms that exhibit tissue-specific expression in the pancreas and liver. In the pancreas, this enzyme plays a role in glucose-stimulated insulin secretion, while in the liver, this enzyme is important in glucose uptake and conversion to glycogen. Mutations in this gene that alter enzyme activity have been associated with multiple types of diabetes and hyperinsulinemic hypoglycemia.
Entrez Gene ID
2645
UniProt ID
P35557
Alternative Names
Glucokinase; Glucokinase (Hexokinase 4); Hexokinase Type IV; HK IV; HK4; Maturity Onset Diabetes Of The Young 2; ATP:D-Hexose 6-Phosphotransferase; Hexokinase D, Pancreatic Isozyme; Hexokinase 4; Hexokinase-4; Hexokinase-D
Function
Catalyzes the phosphorylation of hexose, such as D-glucose, D-fructose and D-mannose, to hexose 6-phosphate (D-glucose 6-phosphate, D-fructose 6-phosphate and D-mannose 6-phosphate, respectively) (PubMed:7742312, PubMed:11916951, PubMed:15277402, PubMed:17082186, PubMed:18322640, PubMed:19146401, PubMed:25015100, PubMed:8325892).

Compared to other hexokinases, has a weak affinity for D-glucose, and is effective only when glucose is abundant (By similarity).

Mainly expressed in pancreatic beta cells and the liver and constitutes a rate-limiting step in glucose metabolism in these tissues (PubMed:18322640, PubMed:25015100, PubMed:8325892, PubMed:11916951, PubMed:15277402).

Since insulin secretion parallels glucose metabolism and the low glucose affinity of GCK ensures that it can change its enzymatic activity within the physiological range of glucose concentrations, GCK acts as a glucose sensor in the pancreatic beta cell (By similarity).

In pancreas, plays an important role in modulating insulin secretion (By similarity).

In liver, helps to facilitate the uptake and conversion of glucose by acting as an insulin-sensitive determinant of hepatic glucose usage (By similarity).

Required to provide D-glucose 6-phosphate for the synthesis of glycogen (PubMed:8878425).

Mediates the initial step of glycolysis by catalyzing phosphorylation of D-glucose to D-glucose 6-phosphate (PubMed:7742312).
Biological Process
Calcium ion import Source: Ensembl
Canonical glycolysis Source: Reactome
Cellular glucose homeostasis Source: GO_Central
Cellular response to insulin stimulus Source: BHF-UCL
Cellular response to leptin stimulus Source: BHF-UCL
Detection of glucose Source: UniProtKB
Glucose 6-phosphate metabolic process Source: UniProtKB
Glucose homeostasis Source: UniProtKB
Glycolytic process Source: GO_Central
NADP metabolic process Source: Ensembl
Negative regulation of gluconeogenesis Source: UniProtKB
Positive regulation of glycogen biosynthetic process Source: UniProtKB
Positive regulation of insulin secretion Source: UniProtKB
Regulation of glycolytic process Source: BHF-UCL
Regulation of insulin secretion Source: BHF-UCL
Regulation of potassium ion transport Source: Ensembl
Cellular Location
Cytoplasm; Nucleus; Mitochondrion. Under low glucose concentrations, GCK associates with GCKR and the inactive complex is recruited to the hepatocyte nucleus.
Involvement in disease
Maturity-onset diabetes of the young 2 (MODY2):
A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.
Familial hyperinsulinemic hypoglycemia 3 (HHF3):
Most common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur.
Diabetes mellitus, non-insulin-dependent (NIDDM):
A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.
Diabetes mellitus, permanent neonatal, 1 (PNDM1):
An autosomal recessive form of permanent neonatal diabetes mellitus, a type of diabetes characterized by onset of persistent hyperglycemia within the first six months of life. Initial clinical manifestations include intrauterine growth retardation, hyperglycemia, glycosuria, osmotic polyuria, severe dehydration, and failure to thrive.
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-GCK Recombinant Antibody (CBFYH-0289)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare